Zafirlukast

Trade Name: 
Accolate
Manufacturer/Distributor: 
AstraZeneca
Classification: 
Leukotriene modifier for asthma
ATC Class: 
R03DC01 - zafirlukast
Status: 
discontinued
Notice of Compliance (yyyy/mm/dd): 
2018/12/31
Presentation: 
Tablet: 20 mg. DIN: 02236606
Comments: 
AstraZeneca is discontinuing zafilukast for business reasons. No other manufacturer in Canada.